6 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
21376605	26	Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11ß-hydroxysteroid dehydrogenase 2 inhibitors.	University of Technology
19914836	2	Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases.	Vienna University of Technology
17201418	105	Discovery and metabolic stabilization of potent and selective 2-amino-N-(adamant-2-yl) acetamide 11beta-hydroxysteroid dehydrogenase type 1 inhibitors.	Abbott Laboratories
17000111	127	Discovery of potent and selective inhibitors of 11beta-HSD1 for the treatment of metabolic syndrome.	Abbott Laboratories
15149687	1	A novel 18 beta-glycyrrhetinic acid analogue as a potent and selective inhibitor of 11 beta-hydroxysteroid dehydrogenase 2.	University of Bath
28537398	114	Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11?-Hydroxysteroid Dehydrogenase Type 1 Inhibitor.	Bristol-Myers Squibb